As of 2025-07-20, the Intrinsic Value of Adapthealth Corp (AHCO) is 14.97 USD. This AHCO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 9.22 USD, the upside of Adapthealth Corp is 62.40%.
The range of the Intrinsic Value is 10.80 - 21.07 USD
Based on its market price of 9.22 USD and our intrinsic valuation, Adapthealth Corp (AHCO) is undervalued by 62.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 10.80 - 21.07 | 14.97 | 62.4% |
| DCF (Growth 10y) | 13.70 - 24.19 | 17.98 | 95.0% |
| DCF (EBITDA 5y) | 14.98 - 32.02 | 23.40 | 153.8% |
| DCF (EBITDA 10y) | 17.86 - 35.13 | 26.15 | 183.6% |
| Fair Value | 3.12 - 3.12 | 3.12 | -66.11% |
| P/E | 11.24 - 17.14 | 14.08 | 52.7% |
| EV/EBITDA | (18.59) - 37.05 | 7.11 | -22.9% |
| EPV | 14.49 - 20.83 | 17.66 | 91.5% |
| DDM - Stable | 4.27 - 9.63 | 6.95 | -24.6% |
| DDM - Multi | 6.56 - 12.20 | 8.60 | -6.7% |
| Market Cap (mil) | 1,244.24 |
| Beta | 0.37 |
| Outstanding shares (mil) | 134.95 |
| Enterprise Value (mil) | 3,154.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.55% |
| Cost of Debt | 6.67% |
| WACC | 6.69% |